Jie Lu

2PUBLICATIONS
0CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 21, 2021
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway.

Xin Wang, Jie Lu, Jing Li

|Nov 17, 2019
Advances in IKBKE as a potential target for cancer therapy.

Min Yin, Xin Wang, Jie Lu

Pageof 1

Frequent Collaborators